Michael Jorgenson has over 30 years of experience in the preclinical contract research industry as a cardiovascular interventionalist. He joined NAMSA in March 2021 via its acquisition of American Preclinical Services, LLC (APS), where he has served as an interventionalist since it became operational in 2006. Mr. Jorgenson received his Bachelor of Science degree in physics and mathematics from the University of Wisconsin (Madison, WI) and served in the United States Army as a Urological Surgical Technician and Procedural Specialist.

CORE COMPETENCIES

• Research interventionalist and scientist (study director) performing device training, feasibility research and Good Laboratory Practice (GLP) safety studies at Mayo Foundation, Minnesota Cardiovascular Research Institute and Charles River Laboratories, Inc.
• Extensive experience having performed tens of thousands of interventional procedures in a variety of models
• Instrumental in the development of cardiovascular preclinical models with extensive experience in coronary and peripheral stenting and other various cardiovascular interventional procedures
• In-house Computer Tomography (CT) expert and Radiation Safety Officer
• 20+ publications and abstracts, including:
  • Vanessa C Lopes-Berkas, Michael A Jorgenson
    Measurement of Peripheral Arterial Vasculature in Domestic Yorkshire Swine by Using Quantitative Vascular Angiography. Journal of the American Association for Laboratory Animal Science, 2011;50(5):628-634).
  • Bayes-Genis, A, Camrud AR, Jorgenson M, Donovan J, Shogren KL, Holmes DR Jr, Schwartz RS
    Pressure rinsing of coronary stents immediately before implantation reduces inflammation and neointimal hyperplasia. J Am Coll Cardiol 2001;38(2):562-8.
  • Altman JD, Camrud A, Camrud L, Jorgenson M, Allen J, Lewis D, Schwartz RS, Chorneky V V, Kerslick GG.
    Intravascular soft X-rays inhibit cellular proliferation.
    Cardiovasc Radiat Med. 2001 Jan 1;2(1):57.

RECENT PROJECTS

• Cardiac interventional therapies, including left atrial appendage (LAA) occlusion, angioplasty, coronary stents, atrial septal defect (ASD) occlusion and cardiac lead
• Peripheral interventional therapies, including aspiration catheter, vascular closure device, vascular and lymphatic sealing, peripheral stents and drug-coated balloon
• CT imaging, including cardiac, abdominal and thoracic